drugset / Trial / NCT06004050

A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand Eczema

NCT06004050

Phase 3 Completed 362 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to evaluate the efficacy of twice-daily applications of delgocitinib cream 20 mg/g compared with cream vehicle in the treatment of participants with moderate to severe chronic hand eczema (CHE).

Timeline

Start
2023-09-05
Primary completion
2024-12-16
Completion
2025-09-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Delgocitinib Small molecule 20 unknown Topical

Indications

No indication recorded.